Department of Pathology ~ Genomic Tumor Board
EVENT DETAILS AND REGISTRATION
Date:April 24, 2017
Time: 09:00 AM - 10:00 AM (PT)
Location:CP Conference Room 2287A
Event Is:
Presenters:Michelle Afkhami, MD Milhan Telatar, MD
ADDITIONAL DETAILS:
Objectives:
- Discuss molecular pathways of solid tumors (Glioma, melanoma, Colon, lung, thyroid, etc.) and hematologic malignancy
- Integrate molecular findings with morphology and clinical information
- Demonstrate diagnostic, prognostic, and therapeutic property of each alteration in the gene detected
- Consensus conference of calling the alterations in respect to a disease and ethnicity of the patient
- Identify available clinical trials for the specific alterations
Who should attend:
Pathologists, solid tumor oncologists, hematology oncologists, hematopathologists, hematologists, and endocrinology fellows, surgery, neurosurgeons, dermatologists, head and neck surgeons, Beckman research scientistsCME credits:1.0 AMA/PRA Category 1 Credit™ The City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. City of Hope designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.TM
R.S.V.P.: Please contact Brenda Phifer Ext. 84401
Contact: